SIGA Technologies is an American biopharmaceutical enterprise that traces its corporate roots and headquarters to the United States, with primary administrative executive offices located in New York City, New York. The company was established to focus on health security, antiviral drug discovery, and medical countermeasures against high-consequence biothreats primarily for domestic and international public health agencies.